Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Clinical Lymphoma, Myeloma & Leukemia|October 26, 2025
Real-World Efficacy Outcomes of Ciltacabtagene Autoleucel in Relapsed Refractory Multiple Myeloma: A Comparative Study with the Cartitude-1 TrialIshita Kamboj, Alma Habib, Darryl Chang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 14, 2022
Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysisMoazzam Shahzad, Sibgha Gull Chaudhary, Muhammad U Zafar, et al.
NPJ Precision Oncology|January 19, 2022
Functional characterization of NPM1-TYK2 fusion oncogeneSudhakiranmayi Kuravi, Riley W Baker, Muhammad Umair Mushtaq, et al.
Transplantation and Cellular Therapy|July 20, 2021
Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisMoazzam Shahzad, Raheel S Siddiqui, Iqra Anwar, et al.
Leukemia & Lymphoma|September 21, 2020
Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemiaMuhammad Umair Mushtaq, Alexandra M Harrington, Sibgha Gull Chaudhary, et al.
Cancers|March 14, 2026
A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment-USMIRC GroupMaha Hameed, Alma Habib, Abdullah Mohammad Khan, et al.
Transplantation and Cellular Therapy|June 13, 2024
Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in MyelomaWilliam Wesson, Danai Dima, Nahid Suleman, et al.
Transplant Immunology|March 21, 2024
Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experienceMatthew McGuirk, Moazzam Shahzad, Muhammad Kashif Amin, et al.
Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.
Expert Review of Hematology|May 27, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myelomaCarmel Awadallah, Shebli Atrash, Barry Paul, et al.
Pageof 8